This FTSE 100 super stock is down more than 20% in July. Time to buy?

This FTSE 100 (INDEXFTSE: UKX) company remains a decent turnaround and growth proposition, in my eyes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Things were going well for shareholders in FTSE 100 international software company Micro Focus International (LSE: MCRO). So well, that one popular share research website labelled it a ‘super stock’.

To qualify for that accolade, a company needs decent quality and value metrics, and good momentum in the share price, which is usually driven by positive momentum in the underlying operations of the business.

Ongoing indigestion from the HPE business

Indeed, the stock had been recovering after weakness induced by its 2017 problematic acquisition of Hewlett Packard Enterprises’ software business. But on 4 July, the shares began to fall. And on 9 July, the firm released its half-year results report for the six months to 30 April.

The adjusted figures revealed revenue down just over 5% compared to the equivalent period the prior year, but that outcome had been flagged previously so was known by the market. Diluted earnings per share increased just over 8.4% and net debt eased back by a little over 12% to $3,807.5m. There’s nothing much in the figures to explain the more than 20% drop we’ve seen in the share price in July so far.

Chief executive Stephen Murdoch said in the report the company is making progress with its “significant program of work” aimed at fully integrating the HPE Software business“through the sustained application of the Micro Focus business model.” The outlook is positive and in line with earlier guidance. City analysts following the firm expect earnings to advance around 10% for the current trading year to October, and 10% again for the year after.

As I see it, there’s nothing drastic in the report to change the case for investing in Micro Focus International, but it’s clear integrating the old HPE business is more of a mouthful than the management bargained for. There’s even a separate section in the narrative headed ‘integration update’, which reveals: The complexities of the HPE Software business integration continue to require detailed attention and substantial programme planning and execution.”

However, the directors are “confident” the firm can deliver on its original thesis, which means making the enlarged Micro Focus “an efficient and optimised platform operating at scale with sector-leading margins and the opportunity to grow further through acquisition.”

Did these director share sales rock the boat?

My guess is the thing that rocked the boat was executive chairman Kevin Loosemore’s sale of 650,000 shares for around £11.6 m over the 10 and 11 July. A cynic might assume the move signals pessimism about the short-term outlook. But Loosemore said he wanted to diversify his investments because he is now 60 years old and had previously held all his wealth in Micro Focus shares. Even after selling, around half his “personal wealth remains in the stock.”

I’m inclined to take his comments at face value and don’t believe his selling is anything more than sensible portfolio management. Micro Focus International remains a decent turnaround and growth proposition in my eyes, and the market could just have handed us an opportunity to buy into the story.

The share price stands at 1,678p as I write, which throws up an earnings multiple just below 10 for the current year and a dividend yield close to 5.4%. I think that’s decent-looking value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold holds shares in Micro Focus International. The Motley Fool UK has recommended Micro Focus. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »